These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16172185

  • 21. Twice-daily dosing of Nelfinavir approved.
    Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888
    [Abstract] [Full Text] [Related]

  • 22. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R, Hamabe Y, Miyaoka T, Hara T, Yoshida K, Oka T, Inoue T.
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [Abstract] [Full Text] [Related]

  • 23. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, Tuberculosis Trials Consortium.
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [Abstract] [Full Text] [Related]

  • 24. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
    Parker AJ, Houston JB.
    Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
    [Abstract] [Full Text] [Related]

  • 25. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
    Avram MJ, Spyker DA, Henthorn TK, Cassella JV.
    Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225
    [Abstract] [Full Text] [Related]

  • 26. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 27. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 28. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A, Ebel D, Liu F, Stone J, Wang A, Zeng W, Chen L, Dilzer S, Lasseter K, Herman G, Wagner J, Krishna R.
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [Abstract] [Full Text] [Related]

  • 29. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K, Kim YS, Kwon KI, Park MS, Lee YJ, Kim KH.
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [Abstract] [Full Text] [Related]

  • 30. Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.
    Vree TB, Waitzinger J, Hammermaier A, Radhofer-Welte S.
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):393-403. PubMed ID: 10475142
    [Abstract] [Full Text] [Related]

  • 31. LC-MS determination and relative bioavailability of doxazosin mesylate tablets in healthy Chinese male volunteers.
    Ma N, Liu W, Li H, Chen B, Zhu Y, Liu X, Wang F, Xiang D, Zhang B.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1049-56. PubMed ID: 17055685
    [Abstract] [Full Text] [Related]

  • 32. Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay.
    Jiang H, Zeng J, Li W, Bifano M, Gu H, Titsch C, Easter J, Burrell R, Kandoussi H, Aubry AF, Arnold ME.
    Anal Chem; 2012 Nov 20; 84(22):10031-7. PubMed ID: 23106420
    [Abstract] [Full Text] [Related]

  • 33. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May 20; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W, Sun J, Zhang TT, Ma B, Cui SM, Chen DW, He ZG.
    Acta Pharmacol Sin; 2006 Dec 20; 27(12):1642-6. PubMed ID: 17112421
    [Abstract] [Full Text] [Related]

  • 35. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN, Falcon RW.
    Pharmacotherapy; 2006 Aug 20; 26(8):1060-8. PubMed ID: 16863482
    [Abstract] [Full Text] [Related]

  • 36. Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
    Crommentuyn KM, Scherpbier HJ, Kuijpers TW, Mathôt RA, Huitema AD, Beijnen JH.
    Pediatr Infect Dis J; 2006 Jun 20; 25(6):538-43. PubMed ID: 16732153
    [Abstract] [Full Text] [Related]

  • 37. Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.
    Xu XS, Dueker SR, Christopher LJ, Lohstroh PN, Keung CF, Cao KK, Bonacorsi SJ, Cojocaru L, Shen JX, Humphreys WG, Stouffer B, Arnold ME.
    Bioanalysis; 2012 Aug 20; 4(15):1855-70. PubMed ID: 22943617
    [Abstract] [Full Text] [Related]

  • 38. Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.
    McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM.
    Clin Infect Dis; 2006 Dec 15; 43 Suppl 4():S235-46. PubMed ID: 17109310
    [Abstract] [Full Text] [Related]

  • 39. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb 15; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

  • 40. The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
    von Hentig N, Babacan E, Lennemann T, Knecht G, Carlebach A, Harder S, Staszewski S, Haberl A.
    J Antimicrob Chemother; 2008 Sep 15; 62(3):579-82. PubMed ID: 18477709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.